Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carmoterol (CHF 4226) Dose-Finding in COPD
NCT00605891Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of carmoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Oct 2006; status: completed.
02
Drugs
carmoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00605891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605891.